Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Enspire Bio
AddedFeb 17, 2024
UpdatedJun 18, 2026
Enspire Bio

Enspire Bio

Seed

Enspire Bio, a drug discovery firm, transforms academic research into therapeutic development for various diseases.

HQ
Los Angeles, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees

Enspire Bio is a drug discovery company focused on transforming academic research into the development of small molecules and peptidomimetics. Partnering with the UCLA Metabolism Unified Research Theme, the company aims to bridge the gap between basic research and translational development, leveraging expertise in cellular energetics, metabolism, and mitochondrial science.

Enspire Bio has made significant strides by utilizing the robust ecosystem within UCLA, fostering collaboration and innovation. Their work has the potential to impact therapeutic development for various diseases, driving advancements in the field of drug discovery.

Enspire Bio - Similar Companies

Continuum Biosciences logo

Continuum Biosciences

Seven Biosciences logo

Seven Biosciences

Pepper Bio logo

Pepper Bio

pepper.bio

Irazu Bio logo

Irazu Bio

irazubio.com

BridGene Biosciences logo

BridGene Biosciences

Promiliad Biopharma logo

Promiliad Biopharma

Energesis Pharmaceuticals logo

Energesis Pharmaceuticals

Generian Pharmaceuticals logo

Generian Pharmaceuticals

generian.com

Epirium Bio logo

Epirium Bio

epirium.com

Discovery Innovations logo

Discovery Innovations

Lucy Therapeutics logo

Lucy Therapeutics

Ensem Therapeutics logo

Ensem Therapeutics

ensemtx.com

Enveda Biosciences logo

Enveda Biosciences

envedabio.com

ZielBio logo

ZielBio

zielbio.com

Inspirna logo

Inspirna

inspirna.com

Enspire Bio - Quick Facts

Who are Enspire Bio's competitors?

Companies similar to Enspire Bio include Continuum Biosciences, Seven Biosciences, Pepper Bio and Irazu Bio.

When was Enspire Bio founded?

Enspire Bio was founded in 2017.

Where is Enspire Bio's headquarters located?

Enspire Bio's headquarters is located in Los Angeles, CA, US.

When was Enspire Bio's last funding round?

Enspire Bio's most recent funding round was for $3.2M (USD) in June 2018.

How much has Enspire Bio raised to-date?

As of Jun 18, 2018, Enspire Bio has raised a total of $3.2M (USD).

How many employees does Enspire Bio have?

Enspire Bio has 7 employees as of Feb 5, 2024.

Enspire Bio - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Data Information
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified